Neurologic clinical trial - Ivy Brain Tumor Center: 2019-07

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT04391595

CONDITION(S): Glioblastoma, glioma, GBM - TRIAL: A Phase 0/2 Study of LY3214996 (ERK Inhibitor) in Combination With Abemaciclib (CDK4 and 6 Inhibitor) in Recurrent Glioblastoma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration

Drug

Abemaciclib

Phase

Phase 0/2

Condition

Glioblastoma glioma GBM

Keywords

Glioblastoma, glioma, GBM | Ivy Brain Tumor Center